Neuropediatrics 2011; 42(2): 55-59
DOI: 10.1055/s-0031-1279726
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Magnetic Resonance Imaging Screening of Cerebral Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: A Pilot Study

P. Giordano1 , V. Cecinati1 , M. Grassi1 , G. C. Del Vecchio1 , F. Dicuonzo2 , M. Palma2 , D. De Mattia1 , N. Santoro1
  • 1Division of Pediatric Oncology-Hematology, Department of Biomedicine in Childhood, University of Bari, Italy
  • 2Department of Neurological and Psychiatric Sciences, Section of Neuroradiology, University of Bari, Italy
Weitere Informationen

Publikationsverlauf

received 14.01.2011

accepted 05.05.2011

Publikationsdatum:
24. Mai 2011 (online)

Preview

Abstract

Background: Thromboembolism is a complication of acute lymphoblastic leukemia therapy in children. The majority of thromboembolic events are cerebral thromboses and deep venous thromboses; many asymptomatic deep venous thromboses are detected in children with acute lymphoblastic leukemia by instrumental screening. The aim of this study was to assess the incidence of asymptomatic cerebral thromboembolic events in children with acute lymphoblastic leukemia (ALL) screened by magnetic resonance imaging and magnetic resonance venography.

Methods: 46 children with acute lympho­blastic leukemia, during the induction phase of the AIEOP ALL 2000 protocol, were stratified into 2 groups. In group “A” cerebral thromboembolic events were suspected following the appearance of suggestive signs and symptoms and confirmed by cerebral magnetic resonance imaging and magnetic resonance venography; in group “B” children underwent a screening by cerebral magnetic resonance imaging and magnetic resonance venography, at set times, in absence of symptoms.

Results: We observed one cerebral thromboembolic event in both groups; we found no differences between early detecting asymptomatic cerebral thromboembolic events among monitored and not monitored patients.

Conclusions: Our study does not seem to suggest a screening for asymptomatic cerebral thromboembolic events in children with ALL during the induction phase.

References

Correspondence

Massimo GrassiMD 

Division of Pediatric Oncology-

Hematology

Department of Biomedicine in

Childhood

University of Bari

Piazza Giulio Cesare 11

70124 Bari

Italy

Telefon: +39/80/559 3277

Fax: +39/80/559 4073

eMail: grassimassimo@hotmail.it